ISMRM WORKSHOP SERIES ~ 12-15 February 2015

ISMRM Workshop on MRI in the Management of Breast Disease: Past, Present & Future
San Francisco, CA, USA
 

OVERVIEW

This workshop is intended to survey the state of breast cancer diagnosis and management, and the place of MRI in the current clinical workflow. It will offer clinical education to workshop attendees with a technical background, and technical education for clinicians new to breast MRI. The advantages and shortcomings of the current techniques used in breast MRI will be discussed. New and emerging approaches, such as DWI, DTI, MRS, 23Na, and elastography will also be presented.

Fundamentally, our goal is to gather a relative number of technical and clinical experts in the field, both supporters and skeptics in the usefulness of MRI in breast disease management. This workshop will provide an open forum for discussion, in which lessons learned are discussed, and the most promising avenues for clinical and technical research are highlighted-if not agreed upon.

Proffered oral presentations will provide visibility to many young and experienced scientists and clinicians working in the field, and to a large array of subtopics in the area of breast imaging.
 

TARGET AUDIENCE
This workshop is designed for:
  • Basic scientists and physicians using MR in breast disease diagnosis and research;
  • Clinicians (oncologists, radiologists, pathologists, surgeons); and
  • Students and Residents starting in the field of breast imaging.
 

EDUCATIONAL OBJECTIVES
Upon completion of this activity, workshop attendees will gain an understanding of:
  • Describe the standard clinical implementation and uses for breast MRI;
  • Examine possible pitfalls associated with the use of MRI in breast disease management;
  • Explain the factors that can impact image quality in breast MRI and list solutions that can mitigate such problems;
  • Review the principles and use of breast DWI;
  • Discuss several emerging technologies that can complement standard dynamic contrast enhanced imaging;
  • Indicate how PET/PEM imaging can complement MRI for breast disease management; and
  • List the advantages and disadvantages of current/future contrast agents.